This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Centre National De La Recherche Scientifique, The University of Nantes, National Institute of Health and Medical Research. Active years: 2013-2025.
Company Filing History:



Years Active: 2013-2025
Title: Monique Mathé: Innovator in Pharmaceutical Chemistry
Introduction
Monique Mathé is a prominent inventor based in Nantes, France. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for the treatment of proliferative diseases. With a total of 2 patents, her work has the potential to impact cancer treatment and bone tissue targeting.
Latest Patents
Monique Mathé's latest patents include innovative compounds designed for medical applications. One of her notable inventions is related to disulfonate stilbenes, which are intended for use in the treatment of proliferative diseases. This patent describes compounds of a general formula where specific groups are selected from hydrogen and pharmaceutically acceptable cations. Additionally, it outlines a pharmaceutical composition that may include another active ingredient, particularly an antineoplastic agent, for treating conditions such as cancer.
Another significant patent involves hydroxy-bisphosphonic acid derivatives, which target bone tissue. This invention details derivatives that correspond to a specific general formula, where various groups are defined to enhance therapeutic or diagnostic applications. The method for preparing these derivatives and their potential uses in medicine are also covered in this patent.
Career Highlights
Throughout her career, Monique Mathé has worked with esteemed institutions such as the University of Nantes and the Centre National de la Recherche Scientifique. Her research has focused on developing innovative solutions to complex medical challenges, particularly in oncology and bone health.
Collaborations
Monique has collaborated with notable colleagues, including Jacques Lebreton and Maxim Egorov. These partnerships have contributed to her research and the advancement of her patented technologies.
Conclusion
Monique Mathé is a trailblazer in pharmaceutical chemistry, with her patents reflecting her commitment to improving medical treatments. Her work continues to inspire advancements in the field, particularly in the fight against proliferative diseases.